New modulators in development by the CF-specific company could provide unique treatment options for the underlying cause of cystic fibrosis for many people with the disease
Site Search
Showing 1 - 2 of 2 results
Press Release
|
April 19, 2022
|
3 min read
Breadth of expertise in business, philanthropy, community engagement, and venture capital to help advance Foundation’s mission
Press Release
|
Aug. 9, 2023
|
4 min read